Quantum Biopharma (QNTM) Operating Expenses (2019 - 2026)

Quantum Biopharma has disclosed Operating Expenses across 8 years of filings, most recently posting $3.0 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at $3.0 million, down 12.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.9 million (up 11.88% YoY), and the FY2025 annual result was $15.3 million, down 5.17% from the prior year.
• Operating Expenses came in at $3.0 million for Q1 2026 at Quantum Biopharma, up from $2.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $9.8 million in Q1 2023 to a low of $1.9 million in Q2 2023.
• The 5-year median for Operating Expenses is $3.4 million (2025), against an average of $3.9 million.
• Peak annual rise in Operating Expenses reached 84.77% in 2024, while the deepest fall reached 77.07% in 2024.
• Quantum Biopharma's Operating Expenses stood at $5.6 million in 2022, then plunged by 41.38% to $3.3 million in 2023, then slumped by 31.84% to $2.3 million in 2024, then increased by 5.14% to $2.4 million in 2025, then grew by 24.98% to $3.0 million in 2026.
• The last three Operating Expenses figures came in at $3.0 million (Q1 2026), $2.4 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.